CVE-2026-4013

CVE-2026-4013 is a medium-severity vulnerability with a CVSS 3.x base score of 6.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-266.

Key facts

Description

A vulnerability was identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown function of the file add_admin.php. Such manipulation leads to improper authorization. The attack may be launched remotely.

Frequently asked questions

What is CVE-2026-4013?
A vulnerability was identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown function of the file add_admin.php. Such manipulation leads to improper authorization. The attack may be launched remotely.
How severe is CVE-2026-4013?
CVE-2026-4013 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2026-4013 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (13th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2026-4013?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2026-4013 have an EU (EUVD) identifier?
Yes. CVE-2026-4013 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-11546.
When was CVE-2026-4013 published?
CVE-2026-4013 was published on 2026-03-12 and last updated on 2026-06-17.

References

Other CWE-266 (Incorrect Privilege Assignment) vulnerabilities

Browse all CWE-266 (Incorrect Privilege Assignment) vulnerabilities →